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Oversight During Research 
HRPO 
– Continuing Review: Informed Consent and 
Protocol Lapses 
• Consent document can only be used through the date 
of expiration to enroll new subjects. 
– Must be renewed at least annually 
• Protocol lapses occur when you allow a protocol to 
expire prior to renewal 
– No new participants may be enrolled. 
– No continuation of treatment may take place without written 
HRPO authorization 
– No federal funds may be expended on human research if 
protocol allowed to lapse 
 
 






Prior to Research 
Obtained in HRPO approved manner 
Record Keeping 
Documentation of all encounters with subject 
Research/Protocol Design 
Inclusion/Exclusion Criteria 
Each enrolled subject must meet 
Enrollment of eligible subjects must be 
documented 
Interventions/Observations 
Subjects must have all expected interventions or 
observations performed and documented 
Consent Issues 
Expect to find one consent per subject having 
data collected 
Consent document must be appropriately 
signed and witnessed 
Consent must be obtained in manner 
approved by HRPO 
Children 
Phone Consent 
Legally Authorized Respresentative 
 




Did the subject receive a copy of the 
signed consent form? 
 
As a good practice, if mailed, send 2 copies 
& document. One comes back to you. 
Participant keeps the other. 
 
 
Consent Form Issues 
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The latest version is not being used 
 
•Check approval and expiration dates on 
consent form  
 





Did the subject receive a copy of the signed 
consent form? 
 
•Document the fact that subject received a 









Did the subject date  
the signed consent form? 
 
Never backdate a consent form 
 
•If subject failed to date the consent form, 
write a note-to-file 
 
 




IRB approval stamp is not on the consent 
form  
 




Hand written changes can not be made to an 










Binder for regulatory documents 
 
•An industry sponsored study will 
require more regulatory documents 
TYPES OF STUDY LOGS  
(NOT ALL ARE NEEDED FOR ALL STUDIES) 
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• Enrollment Log 
• Staff Signature Log 
• Delegation of Responsibility Log 
• Monitoring Log 
• Drug Dispensing/Accountability Log 




•  Protocol identifier 
• Subject identifiers (initials/study number) 
• Randomization and/or kit number 
• Date dispensed & amount dispensed 
• Date returned & amount returned 
•Initials of person dispensing/receiving 
 
Data and Safety Monitoring Board 
(DSMB) Report 
 Failure to submit a copy of the DSMB  
 REPORT to the HRPO at continuing  
 review 
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Investigator Brochure (IB) 
Why is the IB not on file? 
 
Reason #1: It’s too big to keep in the  
   regulatory binder 
 
Solution #1: Write a signed and dated  
   note-to-file indicating where 
   it is located.  
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Investigator Brochure 
Why is the IB not on file? 
 
Reason #2: We’re studying a marketed   
  drug. 
 
Solution #2: Obtain a copy of the package  
    insert. 
17 
Investigator Brochure 
 Why do I need a copy of the IB? 
  
 To provide safety and efficacy data from 
pre-clinical and clinical trials to support 
human exposure by the route, at the 
dosages, for the duration, and in the 
population to be studied. 
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Source Documents 




Source documents include: 
1. hospital records 
2. lab notes 
3. memos 
4. subject diaries 
5. evaluation checklists 







8. copies of transcriptions certified after verification as 
 being accurate and complete 
9. microfiches 
10. photographic negatives 
11. microfilm or magnetic media 




Q.   Why are source documents needed? 
 
A. To document the existence of the  






Q. What are source documents? 
 
A.      It’s wherever data is first recorded  
 (original records  or certified copies) 
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Assistance for Successful Research 
 
 
• Educational Programs 
 
• Staff Training Program 
 
• Research News 
– http://researchnews.wustl.edu 
 
Organizational Offices and Points of Contact 
Available to Help 
 
– Human Research Protection Office 
• 314-633-7400; http://hrpo.wustl.edu 
– Grants & Contracts 
• 314-747-4134; http://grantsandcontracts.wustl.edu 
– Research Office 
• 314-935-5889; http://wuro.wustl.edu 
– Sponsored Project Accounting 
• 314-935-xxxx; http://spa.wustl.edu 
– Center for Clinical Studies 
• 314-747-4000; http://ccs.wustl.edu 
 
 
